# OnCo record paper-her2climb-brain-lin-jco-2020 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-her2climb-brain-lin-jco-2020/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-her2climb-brain-lin-jco-2020" ;
  schema:name "HER2CLIMB brain metastases analysis: intracranial efficacy and survival with tucatinib"@en ;
  schema:description "Among the HER2CLIMB patients with brain metastases, tucatinib doubled the intracranial response rate, cut the risk of intracranial progression or death by about two thirds and lengthened survival."@en ;
  schema:url <https://onco.cc/key-papers/paper-her2climb-brain-lin-jco-2020/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/JCO.20.00775>, <https://pubmed.ncbi.nlm.nih.gov/32468955/> ;
  schema:sameAs <https://doi.org/10.1200/JCO.20.00775> ;
  schema:datePublished "2020"^^xsd:gYear ;
  schema:author "Lin NU, Borges V, Anders C, et al." ;
  onco:cancers <https://onco.cc/cancers/her2-positive-breast-brain-metastases/> ;
  onco:drugs <https://onco.cc/drugs/capecitabine/>, <https://onco.cc/drugs/trastuzumab/>, <https://onco.cc/drugs/tucatinib/> ;
  onco:trials <https://onco.cc/trials/her2climb/> ;
  onco:journals <https://onco.cc/journals/jco/> .